THE JOURNAL OF BIOLOGICAL CHEMISTRY
© 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Vol. 277, No. 47, Issue of November 22, pp. 44817–44825, 2002
Printed in U.S.A.
Misfolded Proteins Are Competent to Mediate a Subset of the
S
Responses to Heat Shock in Saccharomyces cerevisiae*□
Received for publication, May 13, 2002, and in revised form, August 14, 2002
Published, JBC Papers in Press, September 17, 2002, DOI 10.1074/jbc.M204686200
Eleanor W. Trotter‡§, Camilla M.-F. Kao¶储, Ludmilla Berenfeld**, David Botstein‡‡,
Gregory A. Petsko**§§, and Joseph V. Gray‡¶¶
From the ‡Division of Molecular Genetics, Faculty of Biomedical and Life Sciences, University of Glasgow,
Glasgow G11 6NU, United Kingdom, the Departments of ¶Biochemistry and ‡‡Genetics, Stanford University
School of Medicine, Stanford, California 94305, and the **Rosenstiel Basic Medical Sciences Research Center,
Brandeis University, Waltham, Massachusetts 02454-9110
Cells may sense heat shock via the accumulation of
thermally misfolded proteins. To explore this possibility,
we determined the effect of protein misfolding on gene
expression in the absence of temperature changes. The
imino acid analog azetidine-2-carboxylic acid (AZC) is incorporated into protein competitively with proline and
causes reduced thermal stability or misfolding. We found
that adding AZC to yeast at sublethal concentrations sufficient to arrest proliferation selectively induced expression of heat shock factor-regulated genes to a maximum of
27-fold and that these inductions were dependent on heat
shock factor. AZC treatment also selectively repressed
expression of the ribosomal protein genes, another heat
shock factor-dependent process, to a maximum of 20-fold.
AZC treatment thus strongly and selectively activates
heat shock factor. AZC treatment causes this activation
by misfolding proteins. Induction of HSP42 by AZC treatment required protein synthesis; treatment with ethanol,
which can also misfold proteins, activated heat shock factor, but treatment with canavanine, an arginine analog
less potent than AZC at misfolding proteins, did not. However, misfolded proteins did not strongly induce the stress
response element regulon. We conclude that misfolded
proteins are competent to specifically trigger activation
of heat shock factor in response to heat shock.
Eukaryotic cells respond to heat shock by the induction of a
conserved set of proteins, the heat shock proteins, via transcriptional activation of the corresponding genes (1). In the
budding yeast Saccharomyces cerevisiae, two distinct promoter
elements mediate transcriptional activation in response to heat
* This work was supported in part by Grant RS19987 from the Royal
Society (to J. V. G.) and by National Institutes of Health Grants
GM46406 and CA77097 (to D. B.) and Grant HG00983 (to Prof. Patrick
O. Brown). The costs of publication of this article were defrayed in part
by the payment of page charges. This article must therefore be hereby
marked “advertisement” in accordance with 18 U.S.C. Section 1734
solely to indicate this fact.
□
S The on-line version of this article (available at http://www.jbc.org)
contains Table S1.
This paper is dedicated to Prof. Herskowitz.
§ Supported by a Ph.D. studentship from the Biotechnology and Biological Sciences Research Council (United Kingdom).
储 Damon Runyon-Walter Winchell Postdoctoral Fellow.
§§ Planted the seeds for the AZC project while a visiting professor in
the laboratory of Ira Herskowitz at the University of California at San
Francisco.
¶¶ To whom correspondence should be addressed: Div. of Molecular
Genetics, Faculty of Biomedical and Life Sciences, University of
Glasgow, Anderson College Complex, 54 –56 Dumbarton Rd., Glasgow
G11 6NU, UK. Tel.: 141-330-5114; Fax: 141-330-4878; E-mail: J.Gray@
bio.gla.ac.uk.
This paper is available on line at http://www.jbc.org
shock (reviewed in Ref. 2). Heat shock elements (HSEs)1 are
found upstream of many heat-induced genes, e.g. HSP42 and
SSA4. Heat shock factor binds to HSEs and is required for the
induction of HSE-driven genes in response to heat shock.
Stress response elements (STREs) are also found upstream of
many heat shock-induced genes, e.g. CTT1 and DDR1, and bind
the transcription factors Msn2 and Msn4 (2). Loss of both
transcription factors compromises heat shock-induced expression of STRE-containing genes. Some heat shock-induced genes
contain both HSEs and STREs in their promoters, e.g. HSP12,
HSP30, and HSP104. The HSE and STRE regulons constitute
the majority (if not all) of the genes that are specifically induced by heat shock (3).
Rapid upshifts in temperature within the permissive growth
range of yeast (so-called “temperature upshifts”), e.g. 23–36 °C,
result in the transient and selective induction of the heat shock
genes (both HSE- and STRE-containing) and in the transient
and selective repression of the 137 ribosomal protein genes
(Ref. 4 and references therein). Heat shocks to nonpermissive
temperature (e.g. to 42 °C) also cause a global repression of
gene expression not seen upon temperature upshift (4). Repression of the ribosomal protein genes by heat shock is dependent
on activation of heat shock factor. Because these genes do not
contain HSEs, the repression is thought to be indirect (4).
The current model for how cells sense heat shock is as follows
(Ref. 6 and references therein). Heat shock is proposed to cause
the thermal misfolding of a fraction of cellular protein. Because
activation of heat shock factor requires protein synthesis, it is
thought that nascent proteins are the most susceptible to thermal denaturation. Misfolded proteins then bind to cytoplasmic
Hsp70 chaperones. Prior to heat shock, these chaperones are
believed to equilibrate between being bound to heat shock
factor (and inactivating it) and being free in the cytoplasm.
Because misfolded proteins bind Hsp70 chaperones very
tightly, their accumulation upon heat shock is proposed to
titrate Hsp70 chaperones, resulting in liberated and active
heat shock factor. Consistent with this model, misfolded proteins have been detected in mammalian cells upon heat shock
(7). In addition, some HSE-containing genes have been shown
to be induced by the accumulation of nascent proteins (8), by
failure to degrade misfolded and short-lived proteins (9), and by
reduced cytoplasmic Hsp70 function (10). Unfortunately, the
extent, specificity, potency, and mechanism of the above inductions are not known. Alternative triggers for activation of heat
1
The abbreviations used are: HSEs, heat shock elements; STREs,
stress response elements; AZC, a racemic mixture of D- and L-azetidine2-carboxylic acid; WT, wild-type; ORFs, open reading frames; HSF, heat
shock factor.
44817
44818
Misfolded Proteins and Heat Shock
shock factor upon heat shocks have also been proposed, such as
heat shock-induced oxidative stress and membrane changes
(5). The trigger for induction of the STRE-containing genes
upon heat shock is not known (2, 5). If thermally misfolded
proteins indeed trigger some or all of the transcriptional responses to heat shock, then induction of misfolded proteins by
artificial means in the absence of temperature changes should
1) cause many or all of the gene expression changes caused by
heat shock, 2) cause these changes as strongly as does heat
shock, 3) selectively cause these changes, and 4) cause these
changes by the same mechanism as does heat shock.
Azetidine-2-carboxylic acid (AZC) is a toxic analog of proline
and is incorporated into proteins competitively with proline
(11). Because the analog has one less carbon atom in its ring
than does proline, the conformation of the polypeptide backbone is altered when AZC is incorporated in place of proline.
Thus, incorporation of AZC into proteins causes reduced thermal stability or misfolding (12–14). Indeed, AZC-containing
proteins bind avidly to Hsp70 chaperones in vivo (7). AZC thus
affords us an opportunity to study the cell’s response to misfolded proteins in the absence of temperature changes.
We have recently shown that AZC reversibly inhibits proliferation of budding yeast cells, causing arrest in the G1 phase of
the cell cycle within one to two cell generations (15). AZC
treatment and temperature upshift cause G1 arrest by the
same mechanism; arrest is due to lowered G1 cyclin activity
and is dependent on proper activation of heat shock factor in
both cases (15). AZC treatment may therefore activate heat
shock factor via misfolding a fraction of cellular protein. Phenotypic analyses indicate that AZC treatment does not activate
other heat shock-induced responses such as activation of the
cell integrity pathway and accumulation of glycogen and trehalose (15). Thus, AZC treatment appears to induce some (but
not all) of the phenotypic responses to heat shock. In this study,
we examined the effect of AZC treatment on gene expression.
EXPERIMENTAL PROCEDURES
Materials and Chemicals
All chemicals were from Sigma (Dorset, UK). Components of the
growth medium were from BD Biosciences and Fisher. DL-AZC was
used throughout this work, but L-AZC is the active agent in this racemic
mixture.2 Any given concentration of AZC herein refers to the concentration of the racemic mixture.
Plasmids, Yeast Strains, and Manipulations
Liquid media, both rich and minimal, were prepared as described
previously (16). Solid media contained 2% agar. Strains were routinely
grown on yeast/peptone/dextrose (YPD) agar plates at 25 °C. Liquid
cultures were grown in YPD broth.
The strains used in this study were W303-1A (wild-type (WT): MATa
ura3-1 lys2 trp1-1 leu2-3,112 his3-11 can1-100 ade2-1) the laboratory
collections; JVG961 (WT S288c: MAT␣ ra3-52 lys2-801 his3-⌬200 leu2
ade2-101 ho::lacZ) from the laboratory collections; and MH297 (EXA3-1
strain: MAT␣ leu2-3,112 lys2 ura3-52 his3-11,15 trp1-⌬1 EXA3-1) and
a corresponding WT strain, DS10 (MATa), both kind gifts from E. A.
Craig (4). The msn2⌬ msn4⌬ double mutant (MATa STRE-lacZ
msn2⌬::HIS3 msn4⌬::TRP1) and its congenic WT strain (W303-1ASTRE-lacZ) were kind gifts from C. Schüller.
For drug treatments, cells were grown at 30 °C to A600 nm ⫽ 0.05, unless
stated otherwise. AZC and canavanine were dissolved in water to a stock
concentration of 500 mM and added to the growth medium to achieve the
final concentrations specified in individual experiments. Ethanol was
added to the growth medium to a final concentration of 8% (v/v). Cycloheximide (stock solution of 10 mg/ml in ethanol) was added to a final
concentration of 10 g/ml (and hence, the vehicle (ethanol) to 0.1% (v/v)).
For temperature upshift experiments, cells were grown at 23 °C to
A600 nm ⫽ 0.2 and added to an equal volume of YPD medium in a conical
flask preheated at 36 °C in a water bath. Incubation was continued at
36 °C with agitation for the time course of each experiment. All absorb2
G. A. Petsko and J. V. Gray, unpublished observation.
ance measurements were made on a Milton Roy Spectronic 601
spectrophotometer.
Microarray Analysis
RNA Preparation—Yeast strain W303-1A was grown to early log
phase (A600 nm ⬃ 0.4) in 100 ml of YPD medium. AZC was added to a
final concentration of 50 mM, and the cells were incubated for up to an
additional 5 h. The control sample was treated identically, but did not
contain AZC. Cells were harvested by centrifugation for 3 min at 1500 ⫻
g (7000 rpm in a Beckman tabletop centrifuge). The pellet was resuspended in 1 ml of ice-cold water and microcentrifuged for 10 s at 4 °C.
The pellet was then resuspended in 400 l of TES solution (10 mM
Tris-Cl, pH 7.4, 10 mM EDTA, 0.5% SDS), and 400 l of acid phenol was
added with vortexing for 10 s. After a 60-min incubation at 65 °C with
occasional brief vortexing, the sample was placed on ice for 5 min and
then microcentrifuged at 14,000 rpm for 5 min at 4 °C. The aqueous
(top) phase was transferred to a clean 1.5-ml microcentrifuge tube, and
the phenol extraction, incubation, and microcentrifugation were repeated. The aqueous phase was then transferred to a clean 1.5-ml
microcentrifuge tube, and 400 l of chloroform was added with vigorous
vortexing. The total RNA sample was then microcentrifuged for 5 min
at 14,000 rpm at 4 °C. The aqueous phase was transferred to a new
tube, and 40 l of 3 M sodium acetate (pH 5.3) and 1 ml of ice-cold 100%
ethanol were added, followed by microcentrifugation at 14,000 rpm for
5 min at 4 °C to precipitate the RNA. The RNA pellet was washed by
vortexing briefly in ice-cold 70% ethanol and spun down as before. After
resuspension in 50 l of H2O, the concentration of RNA was determined
spectrophotometrically. mRNA was selected from total RNA using a
Poly(A) Olygotex kit (QIAGEN Inc.).
Expression Profiling—For each mRNA sample, 2 g was used for the
cDNA microarray experiments. Changes in the mRNA transcript levels
for the 6219 protein-encoding genes of budding yeast were measured by
comparing transcript abundance at t ⫽ 1 and 5 h relative to t ⫽ 0
(untreated). Fluorescent t ⫽ 0 RNA was prepared by reverse transcription in the presence of Cy3-labeled dUTP, which fluoresces green (maximum at 532 nm) and was used as the common hybridization reference
for the remaining samples. Fluorescent cDNA from the 1- and 5-h
samples was synthesized using Cy5-labeled dUTP, which fluoresces red
(maximum at 635 nm). The Cy5-labeled cDNA representing mRNA
from each time point was mixed with Cy3-labeled t ⫽ 0 cDNA, and the
mixture was hybridized onto a DNA microarray containing ⬃6200 yeast
open reading frames (ORFs). The resulting fluorescence intensities
across the array were measured by a laser scanning microscope. For a
given array spot, the ratio of Cy3 and Cy5 intensities reflects the
transcript levels of the corresponding gene at the time in question
relative to t ⫽ 0, after adjustment by a normalization factor that sets
the average of the log transformed ratios from one array to zero.
Images were analyzed with ScanAlyze (M. B. Eisen),3 and fluorescence ratios (along with numerous quality parameters; see ScanAlyze
manual) were stored in a custom data base. Single spots or areas of the
array with obvious blemishes were flagged and excluded from subsequent analysis.
Northern Probes
Probes were amplified from amplified yeast ORFs (Research Genetics, Huntsville, AL) using universal yeast primers (Research Genetics)
by PCR using Reddy-load PCR mixture (Advanced Biotechnologies Ltd.,
Surrey, UK) according to the manufacturer’s instructions. The genes
that were probed (and their ORF numbers) are as follows: ACT1
(YFL039c), HSP42 (YDR171w), SSA4 (YER103w), HSP12 (YFL014w),
HSP30 (YCR021c), CTT1 (YGR088w), RPL3 (YOR063w), RPL30
(YGL030w), and RPS1a (YLR441c).
Amplified yeast ORFs were run on 1% agarose gels and purified
using the Concert rapid gel extraction system (Invitrogen) according to
the manufacturer’s instructions. Amplified yeast ORFs were labeled
with [32P]dCTP (PerkinElmer Life Sciences) using the Prime-It II random primer labeling kit (Stratagene, La Jolla, CA) and purified using
NucTrap purification columns (Stratagene) according to the manufacturer’s instructions.
Northern Analysis
Extraction of total RNA was performed as previously described (16).
For Northern analysis, 10 g of total RNA was denatured at 65 °C for
5 min before separation on a 1.3% agarose gel containing 10% formaldehyde. The RNA was transferred overnight to Biodyne B membrane
3
Available at www.microarrays.org/software.
Misfolded Proteins and Heat Shock
(0.45 m; Pall Corp., Ann Arbor, MI) in 10⫻ SSC. Membranes were
baked for 2 h at 80 °C and then prehybridized in 50% formamide, 10⫻
Denhardt’s solution, 2% SDS, 5⫻ SSC, and 100 g/ml denatured
salmon sperm DNA for 2 h. The labeled probe was boiled for 5 min
before addition to the membrane in the presence of the prehybridization
mixture. Membranes were hybridized overnight at 42 °C. After stringent washing (2 ⫻ 15 min in 1% SDS and 0.25⫻ SSC at room temperature, 15 min in 0.1% SDS and 0.1% SSC at room temperature, and 30
min in 0.1% SDS and 0.1% SSC at 65 °C), membranes were exposed to
x-ray film (Konica Corp., Tokyo, Japan) at ⫺70 °C with intensifying
screens for an appropriate length of time.
RESULTS
In this study, we set out to determine whether AZC treatment mimics the effect of heat shock on genome-wide gene
expression and, if so, to explore the mechanism by which the
analog causes these effects. Laboratory strain backgrounds
differ in their sensitivity to AZC, as judged by colony formation
on plates (15).4 The concentrations used herein are those just
sufficient to permanently inhibit proliferation of each strain
background under study, unless stated otherwise. All experiments were conducted in the presence of normal amounts of
proline in the growth medium.
We determined the expression changes of the 6129 proteinencoding genes by microarray analysis (see ”Experimental Procedures“) using WT W303-1A cells treated with a growth-inhibiting concentration of AZC (50 mM) for 5 h. We also
performed an equivalent analysis after 1 h of AZC treatment
(50 mM). The result of the latter experiment was qualitatively
similar to the 5-h data set, but with less potent expression
changes.4 Our subsequent analysis therefore focused on the 5-h
data set.
AZC Treatment Does Not Cause Starvation—AZC is an analog of proline and may thereby interfere with proline uptake
or metabolism, resulting in starvation. Nutrient-starved cells
or cells treated with rapamycin, an inhibitor of the TOR (target
of rapamycin) proteins, stop proliferation in the G1 phase of the
cell cycle and enter quiescence-like, non-proliferating states
(17, 20), superficially reminiscent of AZC-arrested cells (15).
We found, by microarray analysis, that AZC treatment (5 h) did
not induce the gene expression changes characteristic of starving cells (21–24), e.g. GAP1, PUT4, SNZ1, and SNZ2 were not
strongly induced by AZC treatment (0.8-, 1.4-, 1.2-, and 1.1fold, respectively). We conclude that AZC does not arrest proliferation by causing starvation. Furthermore, expression of
the proline utilization genes PRO3 and PRO1 was not significantly induced by AZC treatment (1.02- and 1.26-fold, respectively),4 indicating that AZC treatment does not grossly interfere with proline metabolism.
AZC Treatment Selectively Causes Most of the Genome-wide
Gene Expression Changes Caused by Temperature Upshift—
Does AZC treatment mimic heat shock? The expression levels
of 91.8% of the genes did not vary within a factor of 3 upon AZC
treatment, indicating that the analog does not induce the dramatic global changes in gene expression characteristically
caused by severe heat shock. Our subsequent analysis focused
on a comparison with temperature upshift.
We determined the correlations between the microarrayderived expression profiles of AZC-arrested cells (5 h) (this
work) and temperature-upshifted cells (from 23 to 37 °C for 10,
20, and 40 min) (18). This analysis focused on those genes (2470
in total) of known function because data for this subset upon
temperature upshift are publicly available (18). We found that
the correlation between AZC (5 h) and temperature upshift
microarray data sets was highest for the 20-min time point of
temperature upshift, peaking at 0.576. This correlation com4
E. W. Trotter and J. V. Gray, unpublished data.
44819
TABLE I
Selected results from microarray-derived expression changes of known
genes after AZC treatment for 5 h (see Table S1 in the Supplemental
Material for more data)
ORF
Gene name
Protein function
Induction
by AZC
-fold
Most strongly induced by AZC (and strongly induced by temperature
upshift)
YFL014W
HSP12
Heat shock protein
27.96
YLL026W
HSP104
Heat shock protein
22.00
YDR171W
HSP42
Heat shock protein
19.35
YBL075C
SSA3
Heat shock protein
17.52
YER103W
SSA4
Heat shock protein
16.63
YDR258C
HSP78
Heat shock protein
14.74
YBR169C
SSE2
Heat shock protein
14.12
YCR021C
HSP30
Heat shock protein
13.67
Most strongly repressed by AZC (and strongly repressed by
temperature upshift)
YLR441C
RPS1a
Ribosomal protein
0.05
YJL148W
RPA34
RNA polymerase subunit
0.05
YML063W
RPS1b
Ribosomal protein
0.05
YPL220W
RPL1a
Ribosomal protein
0.05
YJL190C
RPS22a
Ribosomal protein
0.05
YGR148C
RPL24b
Ribosomal protein
0.05
Strongly induced by temperature upshift, but not by AZC
YGR088W
CTT1
Catalase T
1.70
YIL101C
XBP1
Transcriptional repressor
0.49
Strongly induced by AZC, but not by temperature upshift
YJL077C
ICS3
Copper homeostasis
6.11
pares well with those between temperature upshift time points:
10 versus 20 min, correlation of 0.793; and 10 versus 40 min,
correlation of 0.582 (18).2 These data suggest that AZC treatment selectively causes the majority (but not all) of the gene
expression changes characteristic of temperature upshift. We
conclude that AZC treatment partially mimics temperature
upshift.
AZC Treatment Selectively Causes Heat Shock Factor-dependent Gene Expression Changes—Which genes are selectively induced by AZC treatment? Expression of a subset of
genes was strongly induced by treatment with AZC (see Table
I for a partial list and Table S1 in the Supplemental Material
for the complete list). Dramatic induction (3–27-fold) was observed for 217 genes. Of the 50 most strongly induced genes of
known function, 46 are also strongly induced after 20 min of
temperature upshift (18). Most conspicuous among these
highly induced genes are those known, or suspected, to be part
of the HSE regulon, e.g. HSP104, HSP82, HSP78, HSP42,
HSP30, HSP12, HSP26, SSA3, SSA4, and SSE2 (3). These
data indicate that AZC treatment mimics temperature upshift
in selectively inducing expression of the HSE regulon. Thus,
AZC treatment may selectively activate heat shock factor.
Activation of heat shock factor directly or indirectly causes
repression of the ribosomal protein genes (4). If AZC treatment
indeed activates heat shock factor, then we expected treatment
with the analog to also repress expression of the ribosomal
protein genes. Expression of a subset of genes (293 in total) was
repressed by a factor of 3 or more (to a maximum of 20-fold) by
AZC treatment (see Table I for a partial list and Table S1 in the
Supplemental Material for the complete list). Of the 50 genes of
known function that are repressed most strongly by AZC treatment, 47 are also strongly repressed by temperature upshift
(18). The majority of these (42 of 47) encode ribosomal proteins,
and repression of these genes by severe heat shock is dependent on heat shock factor (4). Our data suggest that AZC treatment, like temperature upshift, selectively activates heat shock
factor and thereby causes increased expression of HSE-containing genes and repression of the ribosomal protein genes.
Of the 50 genes of known function whose expression is repressed most strongly by temperature upshift (18), 46 were also
44820
Misfolded Proteins and Heat Shock
strongly repressed by AZC treatment. Again, the majority of
these genes encode ribosomal proteins. Thus, AZC treatment
selectively causes the vast majority of the repressions caused
by temperature upshift.
AZC Treatment Fails to Strongly Induce Expression of the
STRE Regulon—Almost all of the genes whose expression is
induced by temperature upshift are components of the HSE or
STRE regulon, or both (3). Does AZC treatment also activate
the STRE regulon? Expression of a significant number of genes
is strongly induced by temperature upshift (18), but not by AZC
treatment. Of the 50 genes encoding proteins of known function
that are most strongly induced after 20 min of temperature
upshift (18), only 25 were strongly induced by AZC treatment.4
Most notable among the genes whose expression is strongly
induced by temperature upshift but not by AZC treatment are
targets of the STRE pathway, e.g. CTT1 and DDR1 (induced
only 1.1- and 2.4-fold, respectively, in response to AZC treatment) and also HXK1, GLK1, TPS1, TPS3, PYK2, HXT2,
HXT5, HXT6, HXT7, PYC1, SDH1, SDH2, SDH4, ZWF1,
ALD4, ALD6, GIP2, GSY1, and GPH1 (3). We conclude that the
STRE regulon is, at best, weakly activated by AZC treatment.
This possibility is supported by our previous finding that AZC
treatment fails to cause accumulation of glycogen and trehalose, a phenomenon dependent on activation of the STRE pathway (15). We conclude that the STRE regulon is much less
sensitive to AZC treatment than is the HSE regulon. To a first
approximation, temperature upshift selectively induces the
STRE and HSE regulons (and thereby represses expression of
the ribosomal protein genes), whereas AZC treatment selectively induces only the latter.
AZC Treatment Causes Few Gene Expression Changes Not
Caused by Temperature Upshift—Although incorporation of
AZC into any given protein molecule is likely to cause dysfunction of that protein, the efficiency of incorporation of AZC in
place of proline in our experiments is likely to be low (see
“Discussion”) (15). Hence, most molecules of any particular
protein in AZC-treated cells are unlikely to contain AZC and
thus are functional. However, proteins that are large, prolinerich, and short-lived are most likely to incorporate at least one
residue of AZC in place of a proline. Thus, AZC treatment may
preferentially inactivate a particular subset of proteins within
the cell and thereby directly cause gene expression changes not
caused by temperature upshift. Surprisingly, we found only a
handful of genes in this set: CUP1-1, CUP1-2, and ICS3 were
induced by AZC treatment, but by not temperature upshift;
ACS2, RPN8, CTS1, and BUD2 were repressed by AZC treatment, but not by temperature upshift (Ref. 18; see Table I for a
partial list and Table S1 in the Supplemental Material for the
complete list of genes whose expression is affected by a factor of
3 or more by AZC treatment). Therefore, the majority of the
gene expression changes caused by AZC treatment are not due
to selective inactivation of any particular subset of proteins by
the analog.
AZC Treatment, Like Temperature Upshift, Does Not Activate the Endoplasmic Reticulum Unfolded Protein Response—
If AZC treatment and temperature upshift cause widespread
misfolding of cellular proteins, then we would expect these
treatments to activate the unfolded protein response pathway
of the endoplasmic reticulum. This signaling pathway is activated by the accumulation of misfolded proteins in the endoplasmic reticulum and promotes transcription (and thus expression) of genes containing unfolded protein response
elements in their promoters (19). Significantly, we found that
genes that were strongly induced by the endoplasmic reticulum
unfolded protein response pathway, e.g. EUG1, PDI1, and
LHS1, were not strongly induced by AZC treatment (1.15-, 1.7-,
and 1.63-fold, respectively).4 Expression of these genes is also
not strongly induced by temperature upshift (18). These findings are consistent with AZC treatment and temperature upshift causing only a low level of protein misfolding in the
endoplasmic reticulum (and presumably throughout the cell).
AZC Treatment Strongly and Robustly Causes Heat Shock
Factor-dependent Gene Expression Changes—We wished to
confirm the salient features of the gene expression changes
detected from microarray profiling by Northern blot analysis.
We also wished to compare the magnitudes of these expression
changes with those caused by temperature upshift. For this
analysis, we used a WT haploid strain of the S288C background
whose proliferation on YPD medium is inhibited by 10 mM AZC
(15). We determined the expression level of the following genes
as a function of time after addition of AZC (10 mM) or upon
temperature upshift (from 23 to 36 °C): ACT1 as a loading
control and a gene sensitive to the global repression characteristic of severe heat shock; the HSE-containing genes HSP42
and SSA4; the HSE- and STRE-containing genes HSP12 and
HSP30; the STRE-containing gene CTT1; the ribosomal protein genes RPS1a and RPL30, containing Rap1-binding sites in
their promoters; and the ribosomal protein gene RPL3, containing an Abf1-binding site in its promoter. The mechanism(s)
regulating expression of the ribosomal protein genes are poorly
understood. However, the promoters of these genes fall into two
classes, those containing potential binding sites for the Rap1
transcription factor and those containing potential binding
sites for the Abf1 transcription factor. We included representatives of both subclasses for completeness. Equal amounts of
total RNA were loaded on each lane, and blots were hybridized
with the same probe at the same time and exposed to the same
film for equal amounts of time for each probing.
The results of the Northern analysis are shown in Fig. 1 (A
and B). In agreement with the results from the microarray
analysis described above, we found that 1) expression of the
HSE-containing genes HSP42, SSA4, HSP12, and HSP30 was
strongly induced by AZC treatment, comparable with, if not
more profoundly than, the peak transient induction of each
gene upon temperature upshift; 2) expression of the STREdriven gene CTT1 was, at best, weakly induced by AZC treatment, but was more strongly induced by temperature upshift;
and 3) expression of the ribosomal protein genes RPL3, RPL30,
and RPS1a (the probe also detected the homologous gene
RPS1b) was strongly repressed by AZC treatment, comparable
with, if not more profoundly than, the peak transient repression caused by temperature upshift. Our Northern analysis
thus confirmed the observations made by microarray analysis
on the gene expression changes caused by AZC treatment. Our
data also demonstrate that the gene expression changes caused
by treatment with a growth-inhibiting concentration of AZC
were at least as strong as the peak inductions caused by temperature upshift, which transiently inhibited proliferation.
Treatment with AZC thus causes heat shock factor-dependent
gene expression changes as strongly as does temperature
upshift.
As expected for continuous incorporation of AZC into newly
synthesized proteins, expression changes caused by treatment
with the analog were persistent and not transient (as is the
case for temperature upshift) and developed slowly. Induction
of HSP42, SSA4, and HSP30 in response to temperature upshift peaked at the 15-min time point. In contrast, induction of
HSP42 and SSA4 by AZC treatment had only begun at the
30-min time point. Curiously, HSP30 was significantly induced
after only 60 min of analog treatment. Such differences in the
kinetics of induction of HSE-containing genes may reflect different sensitivities of the promoters to the activity of heat
Misfolded Proteins and Heat Shock
FIG. 1. AZC treatment mimics temperature upshift. A, AZC
treatment strongly induces expression of HSF-dependent genes and
strongly represses expression of the ribosomal protein genes. JVG961
(WT S288c) cells were grown to logarithmic phase on YPD medium and
treated with AZC (10 mM) at 30 °C. Total RNA was prepared from
samples collected as a function of time after AZC addition. Northern
blots (10 g of RNA/sample) were probed for expression of the indicated
genes. B, temperature upshift induces HSF- and STRE-dependent
genes and represses the ribosomal protein genes. For temperature
upshift, JVG961 cells were grown to logarithmic phase on YPD medium
at 23 °C and subjected to temperature upshift (from 23 to 36 °C). Samples were prepared and analyzed as described for A. Blots were probed
with the same probes and exposed to the same film and for the same
times for each probe.
shock factor revealed only when activation of the transcription
factor is slow.
The microarray and Northern analyses were performed on
different strain backgrounds, yet the results are in excellent
agreement. Although different concentrations of AZC were required to permanently arrest proliferation of the two different
strain backgrounds used (50 mM for W303 versus 10 mM for
S288c), the cellular responses appeared identical in both strain
backgrounds. We infer that the different sensitivities of the
strain backgrounds to AZC does not reflect any fundamental
differences in how the cells respond to the analog once it is
incorporated into protein. Rather, the different sensitivities to
the analog are likely to result from differences in the rate of
uptake or efflux of the analog, in the efficiency of incorporation
of the analog into protein, or in the size of the intracellular pool
of proline.
Induction of HSP42 and SSA4 by AZC Treatment Is Dependent on Heat Shock Factor—Does AZC treatment, like temperature upshift, activate heat shock factor? Heat shock factor is
an essential protein, abrogating the possibility of treating mutants deleted for HSF1 with AZC. Temperature-sensitive alleles of HSF1 are not useful for probing responses in the absence
of temperature change. The EXA3-1 allele of HSF1 encodes a
mutant form of heat shock factor with a single amino acid
residue change in the DNA-binding domain of the protein (4).
EXA3-1 mutants display delayed transcriptional activation of
heat shock factor-regulated genes (by 20 min) and delayed
repression of the ribosomal protein genes upon heat shock to
nonpermissive temperatures (4). The slow time course of AZC
44821
incorporation would preclude accurate detection of such subtle
kinetic delays. However, EXA3-1 mutants are also altered in
the extent of induction of HSE-driven transcripts: some transcripts are induced more strongly in the mutant than in the WT
strain, whereas others are induced more weakly (25). If AZC
treatment activates heat shock factor, then we expect the
EXA3-1 allele to alter the extent, and possibly the persistence,
of activation of HSE-driven transcripts in response to treatment with the analog.
Curiously, the strain background containing the EXA3-1 mutation appeared to be resistant to AZC even up to a concentration of 100 mM, as judged by colony formation on YPD plates.4
As noted above, different strain backgrounds have different
sensitivities to AZC treatment. However, treatment of the
equivalent WT strain with AZC led to a transient inhibition of
proliferation in liquid culture reminiscent of the transient arrest caused by temperature upshift (15). We therefore monitored expression of HSP42 and SSA4 in the EXA3-1 mutant
and in its WT strain as a function of time upon AZC treatment
(40 mM) and upon temperature upshift. As shown in Fig. 2 (A
and B), we found that these HSE-containing genes were indeed
transiently induced in this strain background in response to
AZC treatment. Furthermore, we found that expression of
HSP42 was induced more strongly in the EXA3-1 mutant compared with the WT strain in response to both AZC treatment
and temperature upshift. Expression of HSP42 was also more
persistent in the mutant in response to both treatments. Although there may be subtle effects of the EXA3-1 mutation on
the extent of SSA4 induction in response to both AZC treatment and temperature upshift, expression of this gene was
clearly more persistent in the mutant in response to both
treatments. The EXA3-1 mutation in HSF1 thus affects the
extent or persistence (or both) of induction of HSP42 and SSA4
in response to AZC treatment and temperature upshift. These
data indicate that AZC treatment and temperature upshift
cause induction of HSP42 and SSA4 (and by inference, all
HSE-containing genes) by the same mechanism, namely activation of heat shock factor.
The induction of HSP42 and SSA4 by AZC treatment was
clearly transient for the WT strain used in Fig. 2, in contrast to
the equivalent data for the WT S288c strain shown in Fig. 1.
The persistence of heat shock factor activation in response to
AZC treatment in these strain backgrounds clearly parallels
the persistence of proliferation arrest caused by the analog,
which gratifyingly is also dependent on heat shock factor (15).
Although the reason for the different responses of these two
strain backgrounds to the analog is not known, it is likely to be
due to some combination of differences in the rate of uptake or
efflux of the compound, to different efficiencies of incorporation
of the analog into protein, or to different capacities to degrade
analog-containing peptides. From our data in Figs. 1 and 2, we
cannot compare the relative expression levels of HSP42 and
SSA4 between these two strain backgrounds because different
batches of labeled probes were used for each experiment.
Induction of HSP12 by AZC Treatment Is Partly Dependent
on Msn2 and Msn4 —As determined by the microarray analysis
described above, STRE-containing genes were, at best, poorly
induced by AZC treatment (Table I and Table S1 in the Supplemental Material).4 This observation suggests that Msn2 and
Msn4, the redundant transcription factors required for induction of the STRE regulon, are relatively insensitive to protein
misfolding in the cell. It is known that HSP12 is a member of
both the HSE and STRE regulons. Given that HSP12 expression was very strongly induced by AZC treatment (Fig. 1 (A and
B) and Table I), we set out to determine whether Msn2 and
Msn4 contribute to induction of HSP12 upon AZC treatment.
44822
Misfolded Proteins and Heat Shock
FIG. 2. Induction of HSP42, SSA4, and HSP30 by AZC treatment is dependent on heat shock factor. A, the EXA3-1 mutation affects
the extent and timing of induction of HSF-dependent genes upon temperature upshift. The WT (DS10) and EXA3-1 (MH297) strains were grown
to logarithmic phase on YPD medium and subjected to temperature upshift (from 23 to 36 °C). Total RNA was prepared as a function of time.
Samples (10 g of RNA each) were Northern-blotted, and the blots were probed for expression of the indicated genes. B, the EXA3-1 mutation
affects the extent and timing of induction of HSF-dependent genes upon AZC treatment. The WT (DS10) and EXA3-1 (MH297) strains were grown
to logarithmic phase on YPD medium and treated with AZC (40 mM) at 23 °C. Samples were prepared and analyzed as described for A.
We found that the induction of HSP12 by AZC treatment and
temperature upshift was significantly reduced in a strain deleted for both MSN2 and MSN4 relative to its congenic WT
strain (Fig. 3, A and B). We conclude that Msn2 and Msn4 (and
by inference, the STRE regulon) may indeed be activated by
AZC treatment, but only partially.
Induction of HSP42 by AZC Treatment Is Dependent on
Protein Synthesis—If AZC exerts its effects in vivo by misfolding proteins into which it is incorporated, then the expression
changes caused by AZC treatment should require ongoing protein synthesis. We therefore determined the effect of cycloheximide addition on the ability of AZC treatment to induce expression of HSP42. Treatment of WT S288c cells with
cycloheximide alone or vehicle alone did not alter expression of
HSP42. In contrast, we found that the presence of cycloheximide prevented induction of HSP42 by AZC treatment (Fig.
4A). We infer that ongoing protein synthesis is required for
AZC treatment to induce the HSE regulon, consistent with the
analog functioning via misfolding nascent proteins into which
it is incorporated.
Ethanol Treatment Mimics AZC Treatment—If AZC acts via
misfolding cellular proteins, then we expect other treatments
that misfold proteins in the cell to induce the same spectrum of
gene expression changes as that caused by AZC treatment.
Ethanol can disrupt protein folding by a mechanism distinct
from that of AZC (5). The results of the Northern analysis of
ethanol-treated cells are shown in Fig. 4A. These blots and
those for canavanine-treated cells (see below and Fig. 4B) were
prepared identically to and probed with the same batch of
labeled probe at the same time and exposed to the same film for
the same length of time as the blots shown in Fig. 1 (A and B).
Thus, the data shown in Figs. 1 and 4 are directly comparable.
The concentration of ethanol used in this experiment (8% (v/v))
was just sufficient to stop proliferation of the strain used (WT
S288C).4 We found that ethanol treatment mimicked AZC
treatment: 1) in strongly inducing the expression of genes
regulated by heat shock factor, e.g. HSP42, SSA4, HSP12, and
HSP30; 2) in failing to strongly induce CTT1 (an STRE-driven
gene), in agreement with the very weak activation of STREdriven genes by ethanol reported previously (26); 3) in failing to
repress ACT1 (i.e. no global repression); and 4) in strongly
repressing the expression of the ribosomal protein genes tested.
We conclude that ethanol and AZC treatments, both of which
can misfold proteins, but by very distinct mechanisms, cause
similar gene expression changes attributable to activation of
heat shock factor.
FIG. 3. Induction of HSP12 expression by AZC treatment or
temperature upshift is partially dependent on Msn2 and Msn4.
A, induction of HSP12 expression by AZC treatment partially requires
Msn2 and Msn4. The msn2⌬ msn4⌬ double mutant (msn2,4) and its
congenic WT strain (W303-1A-STRE-lacZ) were grown to logarithmic
phase on YPD medium at 23 °C and treated with AZC (50 mM). Total
RNA was prepared as a function of time. Samples (10 g of RNA each)
were Northern-blotted, and the blots were probed for expression of the
indicated genes. B, induction of HSP12 expression by temperature
upshift partially requires Msn2 and Msn4. The msn2⌬ msn4⌬ double
mutant and its congenic WT strain (W303-1A-STRE-lacZ) were grown
to logarithmic phase on YPD medium at 23 °C and subjected to temperature upshift (from 23 to 36 °C). Total RNA was prepared as a
function of time. Samples (10 g of RNA each) were Northern-blotted,
and the blots were probed for expression of the indicated genes.
Canavanine Treatment Does Not Mimic AZC Treatment—
Canavanine is an arginine analog that, like AZC, is incorporated into protein competitively with the corresponding natural
amino acid (27). Canavanine differs from arginine in the structure of its side chain and, as such, is not expected to significantly alter the conformation of the polypeptide backbone into
which it is incorporated (relative to the same protein containing arginine at the equivalent position(s)). Thus, treatment
Misfolded Proteins and Heat Shock
44823
strongly activate the STRE regulon. It should be noted that, in
our experiments, both AZC and canavanine were present in the
growth medium at concentrations sufficient to inhibit proliferation,4 yet only AZC treatment induced the HSE regulon. Thus,
activation of heat shock factor by AZC treatment is not a
consequence of growth inhibition per se. Rather, the ability of
the analogs (AZC and canavanine) to activate heat shock factor
correlates with their relative capacity to misfold proteins into
which they are incorporated.
Curiously, canavanine treatment robustly induced expression of HSP12 and HSP30, the latter only slowly and weakly.
Although we do not know the mechanistic basis for these inductions, it is tempting to speculate that canavanine treatment
weakly activates both heat shock factor and Msn2/4, sufficiently to induce expression of genes regulated by both pathways (HSP12 and HSP30), but too weakly to drive expression
of genes dependent on one or the other system.
DISCUSSION
FIG. 4. Induced expression of HSF-dependent genes correlates
with protein misfolding. A, induction of HSP42 expression by AZC
treatment requires protein synthesis. JVG961 cells were grown to logarithmic phase on YPD medium at 30 °C and treated with AZC (10 mM),
cycloheximide (10 M), both, or vehicle (0.1% (v/v) ethanol) alone for 2 h
at 30 °C. Total RNA was prepared. The Northern blot (10 g of RNA/
lane) was probed for expression of the indicated genes. B, ethanol
treatment causes similar gene expression changes as does AZC treatment. JVG961 cells were grown to logarithmic phase on YPD medium
at 30 °C and treated with 8% (v/v) ethanol at 30 °C, and total RNA was
prepared as a function of time. Northern blots (10 g of RNA/lane) were
probed for expression of the indicated genes. C, expression changes
caused by canavanine treatment do not closely mimic those caused by
AZC treatment. JVG961 (WT S288c) cells were grown to logarithmic
phase on YPD medium at 30 °C and treated with an inhibitory concentration of canavanine (10 mM) at 30 °C, and total RNA was prepared
from the samples as a function of time. Samples were prepared and
analyzed as described for B. Blots were probed with the same radioactive probes at the same time and autoradiographed on the same film for
the same length of time as each other and as the blots in Fig. 1.
with canavanine is not expected to cause protein misfolding, at
least not to the same extent as does AZC treatment.
We examined the effect of canavanine at a sublethal concentration (10 mM), just sufficient to inhibit cell proliferation, on
gene expression by Northern analysis. Our results are shown in
Fig. 4B. In contrast to ethanol and AZC treatments, canavanine treatment did not significantly induce expression of the
HSE-containing genes HSP42 and SSA3. Canavanine treatment also failed to significantly repress expression of the ribosomal protein genes. We infer that canavanine treatment does
not strongly activate heat shock factor. Canavanine treatment
also failed to induce expression of CTT1 and is thus unlikely to
AZC Causes Protein Misfolding in Vivo—Multiple lines of
evidence indicate that AZC exerts its effects on yeast cells via
incorporation into cellular protein. First, L-AZC, which can be
incorporated into cellular protein, is the active agent in racemic
mixtures, and not D-AZC, which cannot be incorporated.2 Second, AZC inhibits growth of many (but not all) organisms.
AZC-sensitive organisms contain aminoacyl-tRNA synthetases
that can charge tRNAPro with the analog, whereas AZC-resistant organisms do not (reviewed in Ref. 27). Third, the ability of
AZC to arrest cell proliferation is not determined by the absolute concentration of the analog, but rather by the ratio of AZC
to proline in the medium.4 Our microarray data indicate that
AZC does not interfere with proline metabolism per se, consistent with the analog competing with proline for incorporation
into cellular protein. Fourth, induction of the heat shock factorregulated gene HSP42 by AZC treatment is abolished in the
presence of cycloheximide. Thus, activation of heat shock factor
by AZC treatment requires ongoing protein synthesis, consistent with the analog acting via incorporation into cellular protein. Finally, ubc4 ubc5 mutants, which are defective in the
ubiquitin-dependent degradation of short-lived and analogcontaining polypeptides, are hypersensitive to AZC treatment
(15). The simplest explanation for this observation is that, at a
given concentration of AZC, the amount of analog-containing
protein in the cell is higher when these proteins are stable than
when these proteins are unstable. Thus, a concentration of AZC
that is insufficient to arrest cell proliferation in a WT cell would
be sufficient to arrest a cell lacking Ubc4 and Ubc5. Taken
together, these arguments strongly indicate that AZC acts via
incorporation into cellular protein.
Given that incorporation of AZC into protein is known to cause
reduced thermal stability or misfolding (12–14), the effects of the
analog on gene expression are most likely due to its misfolding
proteins. Two lines of evidence support this notion. First, induction of the HSE regulon was also strongly and selectively caused
by treatment with ethanol, another agent capable of misfolding
proteins, but by a mechanism different from that of AZC. Second,
canavanine, an arginine analog that is incorporated into protein
competitively with arginine, did not induce the HSE regulon,
whereas AZC did so efficiently. Canavanine incorporation is not
expected to disrupt protein folding as efficiently as does incorporation of AZC (27). Thus, the relative capacity of the analogs to
induce the HSE regulon correlates with their relative capacity to
misfold proteins into which they are incorporated.
AZC Treatment Selectively Activates Heat Shock Factor—
AZC treatment selectively causes the gene expression changes
attributable to activation of heat shock factor. First, the expression level of only a small fraction of the protein-encoding genes
44824
Misfolded Proteins and Heat Shock
was altered by a factor of 3 or more after 5 h of treatment with
an inhibitory concentration of AZC (8.2% affected in total: 3.5%
induced and 4.7% repressed). Hence, AZC treatment did not
cause any global changes in gene expression, but selectively
affected expression of a discrete subset of genes. Second, HSEcontaining transcripts predominated among those induced by
AZC treatment. Third, the ribosomal protein genes (and coregulated genes encoding components of the translation apparatus) composed the vast majority of the genes that were
strongly repressed by AZC treatment. Repression of the ribosomal protein genes by heat shock is known to be dependent on
activation of heat shock factor (4).
We have confirmed that AZC treatment activates the HSE
regulon (induction of HSE-containing genes and consequent
repression of the ribosomal protein genes) by Northern analysis. Furthermore, we found that AZC treatment activates the
HSE regulon as strongly as, if not more strongly than, does
temperature upshift. We have also shown that a mutation in
heat shock factor affects induction of the HSE-containing genes
HSP42 and SSA4 in response to AZC treatment. Critically, the
mutation alters the induction of these genes in the same way in
response to either AZC treatment or temperature upshift.
Thus, AZC treatment strongly and selectively induces the HSE
regulon by the same mechanism as does temperature upshift,
namely by activating heat shock factor.
Misfolded Proteins Are Competent to Mediate Selective Activation of Heat Shock Factor in Response to Heat Shock—
Based on the above arguments, we conclude that the misfolding of a fraction of cellular protein in the absence of
temperature change mimics heat shock in selectively and
strongly activating heat shock factor. Therefore, misfolded
proteins elicit the appropriate cellular response and do so
sufficiently strongly and selectively for them to be intermediates in the cellular response to heat shock. Given that
misfolded proteins are known to accumulate in heat-shocked
cells (7), they are competent to mediate at least part of the
cellular response to heat shock.
Unfortunately, it is not yet known if misfolded proteins are
kinetically competent to be intermediates in the heat shock
response, i.e. that misfolded proteins accumulate sufficiently
rapidly upon heat shock and that misfolded proteins cause
activation of heat shock factor sufficiently quickly. Although
activation of heat shock factor is slow in response to AZC
treatment, it is likely that equilibration of the analog into the
cellular proline pool prior to incorporation into protein is slow.
The issue of kinetic competence remains unresolved.
If misfolded proteins are intermediates in the cellular response to heat shock, then heat shock factor must be very
sensitive to protein misfolding in cytoplasmic space. Temperature upshift is a very mild environmental change and is unlikely to cause extensive protein misfolding. In addition, AZC
treatment at concentrations sufficient to activate heat shock
factor does not appear to cause widespread protein dysfunction:
1) AZC treatment almost exclusively affects the expression of a
small and discrete subset of genes that are also induced by
temperature upshift; 2) AZC-arrested cells are viable (15); 3)
AZC arrest is reversible (15); and 4) AZC-arrested cells are
responsive to subsequent treatments, e.g. heat shocks (15) and
rapamycin.4 Indeed, neither AZC treatment nor temperature
upshift strongly activates the endoplasmic reticulum unfolded
protein response, even though both treatments should misfold
proteins throughout the cell, including those in the endoplasmic reticulum.
The fraction of protein containing AZC (when cells are
treated with a concentration of the analog just sufficient to
activate heat shock factor) should constitute an upper limit for
the fraction of cellular protein whose misfolding is just sufficient to activate heat shock factor. We are attempting to determine this number.
The STRE Regulon Is Relatively Insensitive to Protein Misfolding—Although AZC treatment profoundly activates the
HSE regulon and genes whose expression is dependent thereon
(e.g. the ribosomal protein genes), it weakly, at best, induces
the STRE regulon. This possibility is supported by our observation that AZC does not lead to the accumulation of glycogen
and trehalose, an STRE regulon-dependent phenomenon (15),
nor does it significantly activate expression of STRE-lacZ reporter constructs.2 However, AZC incorporation into cellular
protein does not appear to affect the activability of the STRE
regulon (15). Rather, AZC treatment simply fails to strongly
activate this regulon. The primary signal for activation of the
STRE regulon by heat shock may be the misfolding of cellular
protein, but with the STRE regulon requiring higher levels of
protein misfolding than those sufficient to activate heat shock
factor (and inhibit proliferation). Indeed, the time course of
activation of CTT1 expression by temperature upshift parallels
that of the heat shock factor-dependent transcripts, consistent
with the notion of a common trigger. Alternatively, the STRE
pathway may primarily respond to heat-induced oxidative
stress or some other stress that coincides with protein misfolding upon heat shock (2, 5). It is clear that Msn2 and Msn4
contribute to the induction of HSP12 by AZC treatment. Given
that the STRE regulon is activated by multiple stresses to the
cell, it is possible that any partial activation of the regulon in
response to analog treatment is caused by an indirect mechanism, e.g. because of proliferation arrest. The mechanism by
which the STRE regulon is activated by heat shocks remains
elusive.
How Do Cells Sense Heat Shocks?—Thermally misfolded protein likely triggers activation of heat shock factor in response to
heat shocks. The sensor for activation of the STRE regulon
upon heat shock remains unclear. However, misfolded protein
is not the sole sensor of heat shock in yeast. The cell integrity
pathway, which is required for acquired thermotolerance and
for maintenance of the cell surface, is activated by heat shocks,
including temperature upshift (28). This pathway is not activated by protein misfolding (15). Rather, the cell integrity
pathway is activated upon heat shock by thermal stress to the
cell surface (28) detected by the plasma membrane sensors
Hcs77 (29) and Mid2 (30). In summary, misfolded protein is
competent to be an intermediate in the cellular response to
heat shock, but it is clearly not the only mechanism by which a
cell can detect thermal stress.
Acknowledgments—We thank I. A. Graham and members of the
Gray and Petsko laboratories for help and support throughout this
project. We thank Josephine McGhie for technical help. We thank Sue
Ann Krause and Mary McElroy for comments on the manuscript. We
thank E. A. Craig and C. Schüller for generous gifts of strains.
REFERENCES
1. Parsell, D. A., and Lindquist, S. (1993) Annu. Rev. Genet. 27, 437– 496
2. Ruis, H., and Schüller, C. (1995) Bioessays 17, 959 –965
3. Boy-Marcotte, E., Lagiel, G., Perrot, M., Bussereau, F., Boudsocq, A., Jacquet,
M., and Labarre, J. (1999) Mol. Microbiol. 33, 274 –283
4. Lopez, N., Halladay, J., Walter, W., and Craig, E. A. (1999) J. Bacteriol. 18,
3136 –3143
5. Piper P. W. (1995) FEMS Microbiol. Lett. 134, 121–127
6. Craig, E. A., and Gross, C. A. (1991) Trends Biochem. Sci. 16, 135–140
7. Beckmann, R. P., Mizzen, L. A., and Welch, W. J. (1990) Science 248, 850 – 854
8. Grant, C. M., Firoozen, M., and Tuite, M. F. (1989) Mol. Microbiol. 3, 213–220
9. Seufert, W., and Jantsch, S. (1990) EMBO J. 9, 543–550
10. Craig, E. A., and Jacobsen, K. (1984) Cell 38, 841– 849
11. Fowden, L., and Richmond, M. H. (1963) Biochim. Biophys. Acta 71, 459 – 461
12. Lane, J. M., Parkes, L. J., and Prockup, D. J. (1971) Biochim. Biophys. Acta
236, 528 –541
13. Zagari, A., Nemethy, G., and Scheraga, H. A. (1990) Biopolymers 30, 951–959
14. Zagari, A., Nemethy, G., and Scheraga, H. A. (1994) Biopolymers 34, 51– 60
15. Trotter, E. W., Berenfeld, L., Krause, S. A., Petsko, G. A., and Gray, J. V.
Misfolded Proteins and Heat Shock
(2001) Proc. Natl. Acad. Sci. U. S. A. 98, 7313–7318
16. Ogas, J., Andrews, B. J., and Herskowitz, I. (1991) Cell 66, 1015–1026
17. Barbet, N. C., Schneider, U., Helliwell, S. P., Stansfield, I., Tuite, M. F., and
Hall, M. N. (1996) Mol. Biol. Cell 7, 25– 42
18. Eisen, M. B., Spellman, P. T., Brown, P. O., and Botstein, D. (1998) Proc. Natl.
Acad. Sci. U. S. A. 95, 14863–14868
19. Sidrauski, C., Chapman, R., and Walter, P. (1998) Trends Cell Biol. 8, 245–249
20. Thomas, G., and Hall, M. N. (1997) Curr. Opin. Cell Biol. 9, 782–787
21. Powers, T., and Walter, P. (1999) Mol. Biol. Cell 10, 987–1000
22. Beck, T., and Hall, M. N. (1999) Nature 40, 689 – 692
23. Cardenas, M. E., Cutler, N. S., Lorenz, M. C., DiComo, C. J., and Heitman, J.
(1999) Genes Dev. 13, 3271–3279
24. Hardwick, J. S., Kurvilla, F. G., Tong, J. K., Shamji, A. F., and Schreiber, S. L.
44825
(1999) Proc. Natl. Acad. Sci. U. S. A. 96, 14866 –14870
25. Halladay, J. T., and Craig, E. A. (1995) Mol. Cell. Biol. 15, 4890 – 4897
26. Schüller, C., Brewster, J. L., Alexander, M. R., Gustin, M. C., and Ruis, H.
(1994) EMBO J. 13, 4382– 4389
27. Fowden, L., Lewis, D., and Tristram, H. (1967) Adv. Enzymol. Relat. Areas
Mol. Biol. 29, 89 –163
28. Kamada, Y., Jung, U. S., Piotrowski, J., and Levin, D. E. (1995) Genes Dev. 9,
1559 –1571
29. Gray, J. V., Ogas, J. P., Kamada, Y., Stone, M., Levin, D. E., and Herskowitz,
I. (1997) EMBO J. 16, 4924 – 4937
30. Verna, J., Lodder, A., Lee, K., Vagts, A., and Ballester, R. (1997) Proc. Natl.
Acad. Sci. U. S. A. 94, 13804 –13809